[A study of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry].
To investigate, at transcriptional and translational level in situ, the abnormal gene expression of the Ki-67 protein in pancreatic carcinoma specimens. 40 pancreatic cancer specimens, 5 normal pancreatic and 4 chronic pancreatitis tissues were studied. A 435 bp cDNA fragment located in codon 2, exon 13 of the Ki-67 antigen gene was amplified by the polymerase chain reaction (PCR). The DIG-labeled cRNA probes were transcribed using a commercially available DIG RNA labeling kit. Localization of the Ki-67 protein and the specific mRNA were studied by combining immunohistochemistry (ICH) with (DIG)-labeled in situ hybridization (ISH). The Ki-67 protein mRNA in formalin-fixed and paraffin-embedded pancreatic tissue sections was successfully localized. Analyzing the Ki-67 mRNA transcription in 17 pancreatic cancer specimens with Ki-67 ICH labeling index > 20%, we found that stronger mRNA signals were also observed in poorly differentiated specimens with Ki-67 index > 50% than in those well differentiated with ICH labeling index 20% - 50%. A high expression of both mRNA and protein was observed in poorly differentiated pancreatic adenocarcinomas. Abnormal overexpression of the gene encoding Ki-67 protein was detected not only at the protein level, but also at the mRNA level in pancreatic tumors. The abnormal overexpression of the Ki-67 protein might be correlated with the central part, exon 13, of the gene.